Taconic Biosciences Launches First and Only Super Immunodeficient Mouse Models Lacking Residual Murine Fc Gamma Receptors, for Improved Antibody Therapy Assessment RENSSELAER, N.Y., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has launched the FcResolv™ NOG portfolio, the first and...

Taconic Biosciences Expands Humanized Mouse Model Production RENSSELAER, N.Y., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces its humanized immune system mice models are now...

Taconic Biosciences Launches New Immuno-oncology Mouse Model RENSSELAER, N.Y., Jan. 31, 2020 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its premier immuno-oncology portfolio with the...

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Northern Oil and Gas, Inc. Of Upcoming Deadline WILMINGTON, Del., Sept. 30, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you, or did you, own shares of Northern Oil and Gas, Inc. (NYSE MKT:NOG)?Did you purchase your shares between...

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Northern Oil and Gas, Inc. - NOG WILMINGTON, Del., Aug. 19, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you, or did you, own shares of Northern Oil and Gas, Inc. (NYSE:NOG)?Did you purchase your shares between March...